Experto en el tratamiento de los síntomas de las pieles secas y atópicas 1- Tiplica GS, Boralevi F, Konno P, Malinauskiene L, Kaszuba A, Laurens C, Saint-Aroman M, Delarue A. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study. J Eur Acad Dermatol Venereol 2018;32,7:11801187. 2- Boralevi F, Saint Aroman M, Delarue A, Raudsepp H, Kaszuba A, Bylaite M, Tiplica GS. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol 2014; 2,11: 1456-1462. 3- Tiplica GS, Kaszuba A, Malinauskien L, Konno P, Boralevi F, Garrigue E, Saint-Aroman M, Delarue A. Prevention of Flares in Children with Atopic Dermatitis with RegularUse of an Emollient Containing Glycerol and Paraffin: A Randomized Controlled Study. Pediatric Dermatology 2017;34,3:282-289. 4- Balaskas E., Szepietowski JC, Bessis D, Ioannides D, Ponticelli C, Ghienne C, Taberly A, Dupuy P. Randomized, double-blind study with glycerol and paraffin in uremicxerosis. Clin J Am Soc Nephrol 2011; 6,4: 748-752. 5- Blanchet-Bardon C, Tadini G, Machado Matos M, Delarue A. Association of glycerol and paraffin in the treatment of ichthyosis in children: an international, multicentric, randomized, controlled, double-blind study. J Eur Acad Dermatol Venereol 2012; 26,8:1014-1019. 6- Martini J, Huertas C, Turlier V, Saint-Martory C, Delarue A. Efficacy of an emollient cream in the treatment of xerosis in diabetic foot: a double-blind,randomized, vehicle controlled clinical trial. J Eur Acad Dermatol Venereol 2017. 7- Cristaudo A, Francesconi L, AmbrifI M, Frasca M, CavallottI C, Sperduti E. Efficacy of an emollient dermoprotective cream inthe treatment of elderly skin affected by xerosis. G Ital Dermatol Venereol 2015;150:297-302. 8- Boralevi F, Meledie N’Djong AP, Yao Yoboue P, Faye O, Dieng MT, Coniquet S, Atadokpede F, Niamba PA, Delarue A, Cazeau C Regression of cutaneous xerosis with emollient treatment in sub-Saharan African patients. Int J Dermatol. 2017;56,4:467-473. 9- Faye O, Meledie N’Djong AP, Diadie S, Coniquet S, Niamba PA, Atadokpede F, Yao Yoboue P, Thierno Dieng M, Zkik A, Castagne C, Zumaglini F, Delarue A. Validation of the Patient-Oriented SCORing for Atopic Dermatitis (PO-SCORAD) for black skin. J Eur Acad Dermatol Venereol 2020;34, 795–799. *IQVIA - Pharmatrend International - Beauty products for family use market (OTC class 83B) farmacia y parafarmacia en Europa (Alemania, Austria, Bélgica, España, Francia, Grecia, Italia, Polonia, Portugal, Eslovaquia, Republica Checa) – Año 2020 – unidades y valores. TRATAMIENTO DE LOS SIGNOS Y SÍNTOMAS DE LA XEROSIS EN PARTICULAR EN VARIAS AFECCIONES CUTÁNEAS TALES COMO: DERMATITIS ATÓPICA, ICTIOSIS… Eficacia probada en varios estudios clínicos(1-9) Efecto hidratante Barrera contra las agresiones externas Para tu piel seca, tu experto diario Fecha de elaboración: Julio 2021 DEXERYL CREMA EN EUROPA*
RkJQdWJsaXNoZXIy NTI5ODA=